In this podcast we take a look at the FDA’s new guidance to facilitate changes to container-closure-system components due to supply constraints, plus updates from suppliers of materials used to deliver COVID-19 vaccines, treatments and other parenteral drugs. For the text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

2020 in Review: The Top 10 Developments

• FDA addresses supply constraints
• Suppliers increase production

Sponsor: Vetter Pharma International GmbH